{"id":"https://openalex.org/W4388626451","doi":"https://doi.org/10.1016/j.ijpharm.2023.123600","title":"Interaction between preservatives and a monoclonal antibody in support of multidose formulation development","display_name":"Interaction between preservatives and a monoclonal antibody in support of multidose formulation development","publication_year":2023,"publication_date":"2023-11-13","ids":{"openalex":"https://openalex.org/W4388626451","doi":"https://doi.org/10.1016/j.ijpharm.2023.123600","pmid":"https://pubmed.ncbi.nlm.nih.gov/37967687"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2023.123600","doi":"https://doi.org/10.1016/j.ijpharm.2023.123600","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2023.123600","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ijpharm.2023.123600","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088231340","display_name":"Sachini P. Karunaratne","orcid":"https://orcid.org/0009-0000-0122-3861","observed_orcids":["https://orcid.org/0009-0000-0122-3861"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sachini P. Karunaratne","raw_affiliation_strings":["Department of Chemistry, The University of Kansas, Lawrence KS, USA"],"raw_orcid":"https://orcid.org/0009-0000-0122-3861","affiliations":[{"raw_affiliation_string":"Department of Chemistry, The University of Kansas, Lawrence KS, USA","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093252239","display_name":"Madeleine C. Jolliffe","orcid":"https://orcid.org/0009-0007-4756-3969","observed_orcids":["https://orcid.org/0009-0007-4756-3969"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Madeleine C. Jolliffe","raw_affiliation_strings":["Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":"https://orcid.org/0009-0007-4756-3969","affiliations":[{"raw_affiliation_string":"Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089012799","display_name":"Isabelle Trayton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Isabelle Trayton","raw_affiliation_strings":["Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004324038","display_name":"Ramesh Kumar Shanmugam","orcid":"https://orcid.org/0000-0002-9932-5539","observed_orcids":["https://orcid.org/0000-0002-9932-5539"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ramesh Kumar Shanmugam","raw_affiliation_strings":["Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061196004","display_name":"Nicholas J. Darton","orcid":"https://orcid.org/0000-0002-5668-6959","observed_orcids":["https://orcid.org/0000-0002-5668-6959"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas J. Darton","raw_affiliation_strings":["Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0002-5668-6959","affiliations":[{"raw_affiliation_string":"Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026266291","display_name":"David D. Weis","orcid":"https://orcid.org/0000-0003-3032-1211","observed_orcids":["https://orcid.org/0000-0003-3032-1211"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David D. Weis","raw_affiliation_strings":["Department of Chemistry, The University of Kansas, Lawrence KS, USA. Electronic address: dweis@ku.edu","Department of Chemistry, The University of Kansas, Lawrence KS, USA"],"raw_orcid":"https://orcid.org/0000-0003-3032-1211","affiliations":[{"raw_affiliation_string":"Department of Chemistry, The University of Kansas, Lawrence KS, USA. Electronic address: dweis@ku.edu","institution_ids":["https://openalex.org/I146416000"]},{"raw_affiliation_string":"Department of Chemistry, The University of Kansas, Lawrence KS, USA","institution_ids":["https://openalex.org/I146416000"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5026266291"],"corresponding_institution_ids":["https://openalex.org/I146416000"],"apc_list":{"value":4050,"currency":"USD","value_usd":4050},"apc_paid":{"value":4050,"currency":"USD","value_usd":4050},"fwci":0.4434,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.537887,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"648","issue":null,"first_page":"123600","last_page":"123600"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-preservatives","display_name":"antimicrobial preservatives","score":0.8859999775886536},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7609999775886536},{"id":"https://openalex.org/keywords/benzyl-alcohol","display_name":"benzyl alcohol","score":0.7639999985694885},{"id":"https://openalex.org/keywords/phenols","display_name":"phenols","score":0.9980000257492065},{"id":"https://openalex.org/keywords/m-cresol","display_name":"m-cresol","score":0.996999979019165},{"id":"https://openalex.org/keywords/protein-conformational-stability","display_name":"protein conformational stability","score":0.8100000023841858},{"id":"https://openalex.org/keywords/hydrogen-deuterium-exchange-mass-spectrometry","display_name":"hydrogen-deuterium exchange mass spectrometry","score":0.7990000247955322},{"id":"https://openalex.org/keywords/differential-scanning-calorimetry","display_name":"differential scanning calorimetry","score":0.8289999961853027},{"id":"https://openalex.org/keywords/subvisible-particles","display_name":"subvisible particles","score":0.8140000104904175},{"id":"https://openalex.org/keywords/storage-stability","display_name":"storage stability","score":0.7559999823570251},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.5419999957084656},{"id":"https://openalex.org/keywords/igg1","display_name":"IgG1","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C67031304","wikidata":"https://www.wikidata.org/wiki/Q274579","display_name":"Preservative","level":2,"score":0.7462798357009888},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6972681879997253},{"id":"https://openalex.org/C39519442","wikidata":"https://www.wikidata.org/wiki/Q904893","display_name":"Differential scanning calorimetry","level":2,"score":0.6313621401786804},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5767508149147034},{"id":"https://openalex.org/C2776460118","wikidata":"https://www.wikidata.org/wiki/Q52353","display_name":"Benzyl alcohol","level":3,"score":0.562274158000946},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5419316291809082},{"id":"https://openalex.org/C193363816","wikidata":"https://www.wikidata.org/wiki/Q1617865","display_name":"Size-exclusion chromatography","level":3,"score":0.5051515698432922},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.4570380449295044},{"id":"https://openalex.org/C2777702071","wikidata":"https://www.wikidata.org/wiki/Q130336","display_name":"Phenol","level":2,"score":0.44685250520706177},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.44349685311317444},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.34681063890457153},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3360190689563751},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2577402591705322},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.19162723422050476},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15284061431884766},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1199067234992981},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001592","descriptor_name":"Benzyl Alcohols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003408","descriptor_name":"Cresols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011310","descriptor_name":"Preservatives, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019800","descriptor_name":"Phenol","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ijpharm.2023.123600","doi":"https://doi.org/10.1016/j.ijpharm.2023.123600","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2023.123600","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:37967687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37967687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ijpharm.2023.123600","doi":"https://doi.org/10.1016/j.ijpharm.2023.123600","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2023.123600","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1517079820","https://openalex.org/W1920643332","https://openalex.org/W1967455529","https://openalex.org/W1969638854","https://openalex.org/W1971234134","https://openalex.org/W1978709728","https://openalex.org/W1979780600","https://openalex.org/W2003684685","https://openalex.org/W2014837879","https://openalex.org/W2019456940","https://openalex.org/W2020890137","https://openalex.org/W2023234283","https://openalex.org/W2042964643","https://openalex.org/W2067608620","https://openalex.org/W2079946015","https://openalex.org/W2125823338","https://openalex.org/W2148799106","https://openalex.org/W2149532677","https://openalex.org/W2517025561","https://openalex.org/W2586724023","https://openalex.org/W2587904144","https://openalex.org/W2728093281","https://openalex.org/W2779190576","https://openalex.org/W2800819859","https://openalex.org/W2888477538","https://openalex.org/W2944937226","https://openalex.org/W2952267359","https://openalex.org/W2952817869","https://openalex.org/W3036466776","https://openalex.org/W3123681476","https://openalex.org/W3132897205","https://openalex.org/W4319598936"],"related_works":["https://openalex.org/W2040700588","https://openalex.org/W2587904144","https://openalex.org/W4416818885","https://openalex.org/W7155705906","https://openalex.org/W3213723349","https://openalex.org/W1972253759","https://openalex.org/W4412957085","https://openalex.org/W4310668159","https://openalex.org/W7206304638","https://openalex.org/W4304689386"],"abstract_inverted_index":{"Multidose":[0],"formulations":[1,14],"have":[2],"patient-centric":[3],"advantages":[4],"over":[5,148],"single-dose":[6],"formats.":[7],"A":[8],"major":[9],"challenge":[10],"in":[11,101,113,155,157,166,185,195],"developing":[12],"multidose":[13],"is":[15,35,54],"the":[16,46,59,83,102,114,127,158,167,186,196],"prevention":[17],"of":[18,31,45,61,104,124,160,169,192,198],"microbial":[19,42],"growth":[20],"that":[21],"can":[22],"potentially":[23],"be":[24],"introduced":[25],"during":[26],"multiple":[27],"drawings.":[28],"The":[29,122],"incorporation":[30],"antimicrobial":[32],"preservatives":[33],"(APs)":[34],"a":[36,76,182],"common":[37],"approach":[38],"to":[39],"inhibit":[40],"this":[41],"growth.":[43],"Selection":[44],"right":[47],"preservative":[48],"while":[49],"maintaining":[50],"drug":[51],"product":[52],"stability":[53,98,138],"often":[55],"challenging.":[56],"We":[57],"explored":[58],"effects":[60],"three":[62],"APs,":[63],"1.1%":[64],"(w/v)":[65,69,73],"benzyl":[66,135,170],"alcohol,":[67],"0.62%":[68],"phenol,":[70],"and":[71,93,134,162],"0.42%":[72],"m-cresol,":[74],"on":[75],"model":[77],"immunoglobulin":[78],"G1":[79],"monoclonal":[80],"antibody,":[81],"termed":[82],"\u201cNIST":[84],"mAb.\u201d":[85],"As":[86],"measured":[87],"by":[88,132,141,175],"hydrogen":[89],"exchange-mass":[90],"spectrometry":[91],"(HX-MS)":[92],"differential":[94],"scanning":[95],"calorimetry,":[96],"conformational":[97,129],"was":[99,110,180],"decreased":[100],"presence":[103,159,168,197],"APs.":[105,121,199],"Specifically,":[106],"flexibility":[107],"(faster":[108],"HX)":[109],"significantly":[111],"increased":[112],"CH2":[115],"domain":[116],"(HC":[117],"238-255)":[118],"across":[119],"all":[120],"addition":[123],"phenol":[125,161],"caused":[126],"greatest":[128],"destabilization,":[130],"followed":[131],"m-cresol":[133,163],"alcohol.":[136,171],"Storage":[137],"studies":[139],"conducted":[140],"subvisible":[142],"particle":[143],"(SVP)":[144],"analysis":[145],"at":[146],"40\u00b0C":[147],"4":[149],"weeks":[150],"further":[151],"revealed":[152],"an":[153,190],"increase":[154],"SVPs":[156],"but":[164],"not":[165],"However,":[172],"as":[173],"monitored":[174],"size":[176],"exclusion":[177],"chromatography,":[178],"there":[179],"neither":[181],"significant":[183],"change":[184],"monomeric":[187],"content":[188],"nor":[189],"accumulation":[191],"soluble":[193],"aggregate":[194]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-11-14T00:00:00"}
